Corrigendum to "Messenger RNA-based vaccines: Past, present, and future directions in the context of the COVID-19 pandemic" [Adv. Drug Delivery Rev. 179 (2021) 114000]

Affiliations

¹ Department of Chemical Engineering, The University of Texas at Austin, Austin, TX, USA.
² Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX, USA.
³ Department of Biomedical Engineering and Chemical Engineering, The University of Texas at San Antonio, San Antonio, TX, USA.
⁴ Department of Chemical Engineering, The University of Texas at Austin, Austin, TX, USA; Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX, USA; Institute for Biomaterials, Drug Delivery, and Regenerative Medicine, The University of Texas at Austin, Austin, TX, USA; Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX, USA; Department of Surgery and Perioperative Care, Dell Medical School, The University of Texas at Austin, Austin, TX, USA. Electronic address: peppas@che.utexas.edu.

Published Erratum

Samagra Jain et al. Adv Drug Deliv Rev. 2022 Oct.

. 2022 Oct:189:114501.

doi: 10.1016/j.addr.2022.114501. Epub 2022 Aug 26.

¹ Department of Chemical Engineering, The University of Texas at Austin, Austin, TX, USA.
² Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX, USA.
³ Department of Biomedical Engineering and Chemical Engineering, The University of Texas at San Antonio, San Antonio, TX, USA.
⁴ Department of Chemical Engineering, The University of Texas at Austin, Austin, TX, USA; Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX, USA; Institute for Biomaterials, Drug Delivery, and Regenerative Medicine, The University of Texas at Austin, Austin, TX, USA; Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX, USA; Department of Surgery and Perioperative Care, Dell Medical School, The University of Texas at Austin, Austin, TX, USA. Electronic address: peppas@che.utexas.edu.

No abstract available

Erratum for

Messenger RNA-based vaccines: Past, present, and future directions in the context of the COVID-19 pandemic.
Jain S, Venkataraman A, Wechsler ME, Peppas NA. Jain S, et al. Adv Drug Deliv Rev. 2021 Dec;179:114000. doi: 10.1016/j.addr.2021.114000. Epub 2021 Oct 9. Adv Drug Deliv Rev. 2021. PMID: 34637846 Free PMC article. Review.